Hepion Pharmaceuticals, Inc. (CTRVP) Net income 2016–2025
Hepion Pharmaceuticals, Inc. (CTRVP) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$8.3MFY2025 · since FY2016: -$14.9M → -$8.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$8.3M | +37.3% |
| FY2024 | -$13.2M | +73.0% |
| FY2023 | -$48.9M | -15.9% |
| FY2022 | -$42.2M | -29.0% |
| FY2021 | -$32.7M | -60.8% |
| FY2020 | -$20.4M | -189.2% |
| FY2019 | -$7.0M | +25.5% |
| FY2018 | -$9.4M | +27.8% |
| FY2017 | -$13.1M | +12.2% |
| FY2016 | -$14.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CTRVP financial trends
CTRVP RevenueCTRVP Net marginCTRVP Gross profitCTRVP Gross marginCTRVP Operating incomeCTRVP Operating marginCTRVP Operating cash flowCTRVP Free cash flowCTRVP Capital expendituresCTRVP Return on equityCTRVP Stock buybacksCTRVP Dividends paidCTRVP Total assetsCTRVP Total liabilitiesCTRVP Shareholders’ equityCTRVP overview →